When Drug Companies Put Profits Before Patients: Your Rights as a Pharmaceutical Whistleblower

The pharmaceutical industry touches millions of lives daily, yet beneath the surface of this critical sector lies a disturbing reality of safety violations, regulatory misconduct, and deliberate non-compliance with FDA standards. When pharmaceutical companies prioritize profits over patient safety, whistleblowers serve as the crucial first line of defense in protecting public health and taxpayer funds.

Understanding Pharmaceutical Fraud and FDA Non-Compliance

Whistleblowers in pharmaceuticals perform a crucial service on behalf of public health and taxpayers when they report or oppose violations of safety laws and fraud. The scope of pharmaceutical misconduct is vast and multifaceted, encompassing everything from manufacturing violations to deliberate misrepresentation of clinical trial data.

Current Good Manufacturing Practices (“cGMPs”) are meant to serve as baseline regulations to ensure proper design, monitoring, and control of manufacturing processes and facilities of pharmaceutical companies. Failure to adhere to cGMPs constitutes a violation of FDA regulations and can expose a company to a lawsuit under the FCA. These violations can have devastating consequences for patients who rely on medications for their health and survival.

Common Types of FDA Violations That Warrant Whistleblowing

Pharmaceutical companies engage in various forms of misconduct that put both patients and government programs at risk:

• Off-Label Marketing: The law prohibits drug manufacturers from marketing or promoting a drug for a use that the FDA has not approved. A company found to have engaged in off-label marketing while receiving funding from federal healthcare programs is in violation of the FCA.
• Manufacturing Violations: Instances of cGMP violations can include keeping incomplete testing records and failing to keep investigation data, manufacturing goods for sale that the FDA disapproves, and employing individuals prior to their training completion.
• Clinical Trial Manipulation: Pharmaceutical companies and medical device manufacturers must obtain FDA approval prior to the sale of their products. If the company submits false data during any stage of the clinical trial to obtain approval, they are breaking the law and can be held responsible through their crime with the help of a brave whistleblower.
• Kickback Schemes: The federal healthcare Anti-Kickback statute broadly prohibits drug companies from offering or paying any remuneration, in cash or kind, directly or indirectly, to induce physicians or others to order or recommend drugs that may be paid for by a federal healthcare program. A company found to have violated the Anti-Kickback statute while receiving funding from federal healthcare programs is in violation of the FCA.

The Financial Impact of Pharmaceutical Fraud

Pharmaceutical companies have paid out over $20 billion in fines, penalties, and settlements. Yet, the never-ending and continuous reports of new violations by pharmaceutical companies suggest that these fraudulent practices are simply a standard operating procedure in the industry. This staggering figure represents just the tip of the iceberg, as many violations go undetected without brave individuals willing to step forward.

Recent high-profile cases demonstrate the severity of these violations. GlaxoSmithKline paid the government $600 million to settle the case along with a $150 million criminal fine. The Justice Department awarded our client $96 million of the federal portion of the recovery, the then-largest reward for a single whistleblower.

Legal Protections and Rewards for Pharmaceutical Whistleblowers

Understanding your rights as a potential pharmaceutical whistleblower is crucial. There are a number of other federal and state laws which protect pharmaceutical employees who blow the whistle on their company’s wrongdoing. These protections extend beyond mere job security to encompass comprehensive legal safeguards.

Laws also protect whistleblowers from facing retaliation from their employers. Retaliation can take many forms and includes such treatment as being fired, being demoted or denied a promotion, having one’s hours unreasonably decreased, having one’s wages or earnings unjustly withheld, and more. Any negative employment action that is based on one’s status as a whistleblower can be considered retaliation.

The financial incentives for whistleblowing are substantial. If the information proves useful in putting an end to the company’s abusive practices, the whistleblower may be able to claim a reward of up to 30% of the net proceeds recovered by the government. Generally, the award is between 10 and 30 percent of what gets recovered. This can lead to huge totals, which mean substantial whistleblower awards, even for whistleblowers who only get 10 percent of the case’s proceeds.

Why Professional Legal Representation Matters

Navigating pharmaceutical whistleblowing cases requires specialized expertise and unwavering commitment to justice. When facing powerful pharmaceutical corporations with virtually unlimited resources, having experienced legal counsel becomes essential for success.

If you’re considering reporting pharmaceutical fraud or FDA violations in the New York area, consulting with a qualified whistleblower attorney Brooklyn, NY can provide the guidance and protection you need. The Howley Law Firm understands the complexities of pharmaceutical whistleblowing cases and is committed to protecting both public health and the rights of those who courageously step forward.

Our mission is to give people the same high-quality legal representation​ that corporations have at large law firms. At The Howley Law Firm, we care about you. We will fight for your rights to compensation and justice. Every year, the government pays hundreds of millions of dollars to whistleblowers who help stop fraud, waste, and abuse in the Medicare and Medicaid programs. Whistleblowers are also entitled to significant legal protections. If you have evidence of Medicare or Medicaid fraud, call us today to learn if you qualify for a reward and legal protections.

Taking Action: Your Role in Protecting Public Health

Fortunately, there’s a powerful check against pharmaceutical fraud: whistleblowers. Because pharmaceutical companies often go to great lengths to cover up their activities and conceal them from regulators, whistleblowers are often the only people who can bring them to justice. Whistleblowers who report these violations are critical to uncovering these frauds, recovering lost taxpayer money, and stopping unsafe pharmaceutical production.

The decision to become a pharmaceutical whistleblower is never easy, but it’s often necessary to protect public health and ensure accountability in an industry that affects millions of lives. Pharmaceutical fraud whistleblower cases benefit the public by recovering taxpayer funds, promoting drug safety, and holding companies accountable for misconduct. They also enhance transparency and encourage ethical industry practices, ultimately safeguarding public health and resources.

If you have knowledge of pharmaceutical fraud, manufacturing violations, or FDA non-compliance, remember that anyone may file a complaint reporting an allegation of regulatory misconduct. The FDA encourages people submitting allegations to include supporting information and contact information in case additional information is needed for the FDA to understand the allegation and act on the report; however you can choose to submit a report anonymously.

Your courage to speak up could prevent harm to countless patients while ensuring that those who violate public trust are held accountable. With proper legal representation and the protections afforded by federal whistleblower laws, you can make a difference while safeguarding your own rights and future.